Walder Wyss acted as counsel to the Joint Lead Managers on the issuance. Sandoz, a global leader in the generics and biosimilars markets successfully placed EUR...
Sandoz’s €600 Million Eurobond Issuance
Sandoz’s CHF2.65 Billion Bonds Offering
Advestra advises Sandoz on the placement of inaugural bonds in the equivalent of CHF 2.65 bn. Following its spin-off from Novartis on 4 October 2023, Sandoz,...
Novartis’ Spin-off of Sandoz’s Generic and Biosimilar Drugs Business
Bär & Karrer acted as Swiss legal and tax advisor to Novartis and Sandoz. Cravath represented Novartis as U.S. tax counsel. Novartis has completed the spin-off...
Biogen Inc. et al. v. Sandoz Inc. et al.
Morrison Foerster and Young Conaway successfully defeated Biogen’s motion for a preliminary injunction for their client Sandoz, Inc. in an ongoing patent infringement case for a...